These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 26224169)

  • 21. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.
    Prasad R
    Indian J Tuberc; 2010 Oct; 57(4):180-91. PubMed ID: 21141336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
    Barnard M; Albert H; Coetzee G; O'Brien R; Bosman ME
    Am J Respir Crit Care Med; 2008 Apr; 177(7):787-92. PubMed ID: 18202343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolving epidemic of drug-resistant tuberculosis among children in Cape Town, South Africa.
    Seddon JA; Hesseling AC; Marais BJ; Jordaan A; Victor T; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Jul; 16(7):928-33. PubMed ID: 22583610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GenoType® MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea.
    Lyu J; Kim MN; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):120-4. PubMed ID: 23232012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug Resistance among Pulmonary Tuberculosis Patients in Calabar, Nigeria.
    Otu A; Umoh V; Habib A; Ameh S; Lawson L; Ansa V
    Pulm Med; 2013; 2013():235190. PubMed ID: 24078872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lab-on-Chip-Based Platform for Fast Molecular Diagnosis of Multidrug-Resistant Tuberculosis.
    Cabibbe AM; Miotto P; Moure R; Alcaide F; Feuerriegel S; Pozzi G; Nikolayevskyy V; Drobniewski F; Niemann S; Reither K; Cirillo DM; ;
    J Clin Microbiol; 2015 Dec; 53(12):3876-80. PubMed ID: 26246486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transmission and Progression to Disease of Mycobacterium tuberculosis Phylogenetic Lineages in The Netherlands.
    Nebenzahl-Guimaraes H; Verhagen LM; Borgdorff MW; van Soolingen D
    J Clin Microbiol; 2015 Oct; 53(10):3264-71. PubMed ID: 26224845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.
    Whitfield MG; Warren RM; Streicher EM; Sampson SL; Sirgel FA; van Helden PD; Mercante A; Willby M; Hughes K; Birkness K; Morlock G; van Rie A; Posey JE
    J Clin Microbiol; 2015 Nov; 53(11):3633-5. PubMed ID: 26292310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic diversity and molecular epidemiology of multidrug-resistant Mycobacterium tuberculosis in Minas Gerais State, Brazil.
    Dantas NG; Suffys PN; Carvalho Wda S; Gomes HM; de Almeida IN; de Assis LJ; Augusto CJ; Gomgnimbou MK; Refregier G; Sola C; de Miranda SS
    BMC Infect Dis; 2015 Aug; 15():306. PubMed ID: 26231661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool.
    Romero K; Clay R; Hanna D
    Clin Infect Dis; 2015 Aug; 61 Suppl 1():S5-9. PubMed ID: 26224771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm.
    Gumbo T; Pasipanodya JG; Nuermberger E; Romero K; Hanna D
    Clin Infect Dis; 2015 Aug; 61 Suppl 1():S18-24. PubMed ID: 26224768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of isoniazid preventive therapy on tuberculosis or death in persons with HIV: a retrospective cohort study.
    Ayele HT; van Mourik MS; Bonten MJ
    BMC Infect Dis; 2015 Aug; 15():334. PubMed ID: 26269094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.
    Gupta RK; Lucas SB; Fielding KL; Lawn SD
    AIDS; 2015 Sep; 29(15):1987-2002. PubMed ID: 26266773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tuberculosis is frequently diagnosed within 12 months of diabetes mellitus.
    Heo EY; Choi NK; Yang BR; Koo BK; Hwang SS; Lee CH; Kang YA
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1098-101. PubMed ID: 26260832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study.
    Garfein RS; Collins K; Muñoz F; Moser K; Cerecer-Callu P; Raab F; Rios P; Flick A; Zúñiga ML; Cuevas-Mota J; Liang K; Rangel G; Burgos JL; Rodwell TC; Patrick K
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1057-64. PubMed ID: 26260824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the national tuberculosis surveillance program in Haiti.
    Salyer SJ; Fitter DL; Milo R; Blanton C; Ho JL; Geffrard H; Morose W; Marston BJ
    Int J Tuberc Lung Dis; 2015 Sep; 19(9):1045-50. PubMed ID: 26260822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rate of tuberculosis infection in children and adolescents with household contact with adults with active pulmonary tuberculosis as assessed by tuberculin skin test and interferon-gamma release assays.
    Ferrarini MA; Spina FG; Weckx LY; Lederman HM; De Moraes-Pinto MI
    Epidemiol Infect; 2016 Mar; 144(4):712-23. PubMed ID: 26234295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Relationship between Extensively Drug-Resistant Tuberculosis and Multidrug-Resistant Gram-Negative Bacilli.
    Zhao JN; Zhang XX; He XC; Yang GR; Zhang XQ; Li HC
    PLoS One; 2015; 10(7):e0134998. PubMed ID: 26230499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.
    Chanda E
    BMC Infect Dis; 2024 Apr; 24(1):364. PubMed ID: 38556907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.